396.00
-1.00
(-0.25%)
As of January 30 at 5:24:48 PM GMT+2. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
36,831.00
67,642.00
95,146.00
40,358.00
Total Liabilities Net Minority Interest
6,747.00
10,801.00
10,107.00
4,871.00
Total Equity Gross Minority Interest
30,084.00
56,841.00
85,039.00
35,487.00
Total Capitalization
30,084.00
56,841.00
85,039.00
35,487.00
Common Stock Equity
30,084.00
56,841.00
85,039.00
35,487.00
Capital Lease Obligations
1,032.00
4,847.00
6,006.00
203.00
Net Tangible Assets
30,084.00
56,841.00
85,039.00
35,487.00
Working Capital
27,703.00
45,723.00
81,724.00
33,749.00
Invested Capital
30,084.00
56,841.00
85,039.00
35,487.00
Tangible Book Value
30,084.00
56,841.00
85,039.00
35,487.00
Total Debt
1,032.00
4,847.00
6,006.00
203.00
Share Issued
18,598.56
18,421.85
18,331.51
14,587.93
Ordinary Shares Number
18,598.56
18,421.85
18,331.51
14,587.93
12/31/2020 - 7/22/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PPBT.TA Purple Biotech Ltd
6.00
0.00%
ORMP.TA Oramed Pharmaceuticals Inc.
796.60
-0.69%
LCTX.TA Lineage Cell Therapeutics, Inc.
220.60
0.00%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
XTLB XTL Biopharmaceuticals Ltd.
1.5899
-1.25%
SCNI Scinai Immunotherapeutics Ltd.
3.5887
+3.72%
PPBT Purple Biotech Ltd
3.2500
-3.85%
BLRX.TA BioLineRx Ltd.
2.2000
-12.00%
ORMP Oramed Pharmaceuticals Inc.
2.2400
+1.82%
EVGN Evogene Ltd.
1.5700
+1.29%